K-numberK242962
Device nameTelemetry Monitor 5500 Release 4.0 (867232)
ApplicantPhilips Medizin Systeme Böblingen GmbH
Product codeMHX
Device classClass II
Decision dateMay 5, 2025
DecisionSubstantially Equivalent
Regulation870.1025
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Telemetry Monitor 5500 Release 4.0 is a battery-operated, patient-worn monitor with a touchscreen display that monitors and records multiple physiological parameters—including ECG, SpO2, and respiration rate—in hospitalized adults and pediatric patients and during in-hospital transport. It communicates wirelessly via 1.4 GHz radio to a central Patient Information Center and is not intended for home use.

Technological characteristics

The subject device has an updated user interface with a modernized exterior and graphical display improvements; improved battery runtime (8–31 hours for ECG-only mode with Lithium-ion vs. 9–30 hours in predicate); end-to-end data encryption and authentication via Smart-hopping 2.0 (new feature); simplified battery door design eliminating the need for a separate door when using Lithium-ion batteries; and an integrated acoustic back volume in the speaker assembly. Physiological parameters, accessories, and core monitoring algorithms (EASI, Hexad, ST/AR) remain identical to the predicate.

Test standards cited

IEC 60601-1 (electrical safety), ANSI AAMI IEC 60601-1-2 (EMC), IEC 60601-1-6 (usability), ANSI AAMI IEC 62366-1 (usability engineering), ANSI AAMI IEC 60601-1-8 (alarm systems), ANSI AAMI IEC 60601-2-27 (ECG monitoring), IEC 80601-2-49 (multifunction patient monitoring), ISO 80601-2-61 (pulse oximetry), ANSI AAMI IEC 62304 (software lifecycle), and FDA guidance on pulse oximeter 510(k)s.

Substantial equivalence argument

The subject device has identical intended use, patient population, physiological parameters monitored, ECG/SpO2 accessories, and core arrhythmia detection algorithms as the predicate MX40. Functional testing confirms equivalent accuracy performance. Minor technological differences—improved battery life, user interface modernization, and added cybersecurity features—do not alter clinical performance or safety. The simplified battery design was validated through usability testing. Enhanced encryption supports the same wireless communication method and does not raise safety concerns. These improvements represent evolutionary refinements to an unchanged clinical function, preserving substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →